{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T21:25:53Z","timestamp":1793913953198,"version":"4.8.0"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Applied Radiation and Isotopes"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.apradiso.2026.112855","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T23:41:14Z","timestamp":1787701274000},"page":"112855","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["[177Lu] Lu-PSMA-I&T for prostate cancer radioligand therapy: A radiopharmacy\u2019s journey from synthesis to cost-effectiveness"],"prefix":"10.1016","volume":"238","author":[{"given":"Michela","family":"Aurilio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costantina","family":"Maisto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Morisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aureliana","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica Josefa","family":"Buonanno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"de Marino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Talamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Manna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Nappo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"D\u2019 Ambrosio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Squame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piera","family":"Maiolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Secondo","family":"Lastoria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.apradiso.2026.112855_bib1","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/jlcr.3227","article-title":"Guidance on current good radiopharmacy practice for the small-scale preparation of radiopharmaceuticals using automated modules: a European perspective","volume":"57","author":"Aerts","year":"2014","journal-title":"J. Label. Compd. Radiopharm."},{"issue":"3","key":"10.1016\/j.apradiso.2026.112855_bib2","article-title":"Cutler et all, Global Issues of Radiopharmaceutical Access and Availability: a Nuclear Medicine Global Initiative Project","volume":"62","author":"Cathy","year":"2021","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.apradiso.2026.112855_bib3","doi-asserted-by":"crossref","DOI":"10.1007\/s00259-022-05744-6","article-title":"Matched-pair analysis of [177Lu] Lu PSMA I&T and [177Lu] Lu PSMA-617 in patients with metastatic castration-resistant prostate cancer","author":"Hartrampf","year":"2022","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"issue":"4","key":"10.1016\/j.apradiso.2026.112855_bib4","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s00259-022-05694-z","article-title":"EANM position on the in\u2010house preparation of radiopharmaceuticals","volume":"49","author":"Hendrikse","year":"2022","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"issue":"9","key":"10.1016\/j.apradiso.2026.112855_bib5","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1007\/s00259-023-06255-8","article-title":"Joint EANM\/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT)","volume":"50","author":"Kratochwil","year":"2023","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"issue":"12","key":"10.1016\/j.apradiso.2026.112855_bib6","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.3390\/molecules27123862","article-title":"Analysis of pros and cons in using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007: Production, Costs, apd PET\/CT Apclications in Patiants with Prostape Cancer","volume":"27","author":"Maisto","year":"2022","journal-title":"Molpcules"},{"key":"10.1016\/j.apradiso.2026.112855_bib7","series-title":"Lutetium (177Lu) Zadavotide Guraxetan Injection","year":"2024"},{"issue":"10","key":"10.1016\/j.apradiso.2026.112855_bib8","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.2967\/jnumed.121.262308","article-title":"PSMA-targeted therapeutics: a tale about law and economics","volume":"62","author":"Notni","year":"2021","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.apradiso.2026.112855_bib9","article-title":"Prostate-specific membrane antigen radioligand therapy using (177) Lu-PSMA I&T and (177) Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer: comparison of safety, biodistribution and dosimetry","author":"Schuchardt","year":"2021","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.apradiso.2026.112855_bib10","first-page":"81","article-title":"Prostate-specific membrane antigen expression in normal and malignant human tissues","volume":"3","author":"Silver","year":"1997","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.apradiso.2026.112855_bib11","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/jlcr.3846","article-title":"Automated synthesis of 68 Ga\/177 Lu-PSMA on the Trasis miniAllinOne","volume":"63","author":"S\u00f8rensen","year":"2020","journal-title":"J. Label. Compd. Radiopharm."},{"issue":"2","key":"10.1016\/j.apradiso.2026.112855_bib12","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2214\/AJR.18.20845","article-title":"Radioligand therapy with 177Lu-PSMA for metastatic castration-resistant prostate cancer: a systematic review and meta-analysis","volume":"213","author":"Yadav","year":"2019","journal-title":"AJR Am. J. Roentgenol."}],"container-title":["Applied Radiation and Isotopes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969804326004392?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969804326004392?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:47:23Z","timestamp":1793911643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969804326004392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":12,"alternative-id":["S0969804326004392"],"URL":"https:\/\/doi.org\/10.1016\/j.apradiso.2026.112855","relation":{},"ISSN":["0969-8043"],"issn-type":[{"value":"0969-8043","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"[177Lu] Lu-PSMA-I&T for prostate cancer radioligand therapy: A radiopharmacy\u2019s journey from synthesis to cost-effectiveness","name":"articletitle","label":"Article Title"},{"value":"Applied Radiation and Isotopes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apradiso.2026.112855","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"112855"}}